Structure Therapeutics (GPCR) EPS (Basic) (2022 - 2026)
Structure Therapeutics (GPCR) posted quarterly EPS (Basic) of -$0.35 for Q1 2026, down 28.42% year-over-year from -$0.49 in Q1 2025, and down 134.92% quarter-over-quarter from $1.0 in Q4 2025.
Analysis
Structure Therapeutics (GPCR) EPS (Basic) (2022 - 2026) Analysis & Trends
Structure Therapeutics' EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.35 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 28.42% year-over-year to -$0.35; the TTM figure through Mar 2026 stood at -$0.12 (up 33.08% YoY), while the FY2025 annual figure was $0.02, up 133.71% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.35, down from $1.0 in the prior quarter.
- The five-year high for EPS (Basic) was $1.0 in Q4 2025, with the low at -$1.42 in Q2 2022.
- The 5-year median for EPS (Basic) is -$0.2 (2023), against an average of -$0.17.
- Peak annual rise in EPS (Basic) reached 106.35% in 2025, while the deepest fall reached 103.36% in 2025.
- Structure Therapeutics' EPS (Basic) stood at $0.43 in 2022, then grew by 17.38% to $0.51 in 2023, then slipped by 4.02% to $0.49 in 2024, then surged by 106.35% to $1.0 in 2025, then slumped by 134.92% to -$0.35 in 2026.
- Business Quant data shows GPCR's EPS (Basic) at -$0.35 in Q1 2026, $1.0 in Q4 2025, and -$0.37 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Structure Therapeutics | 10.32 Bn | 10.32 Bn | - | -0.49 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.49 |
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | 0.34 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.36 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.21 |
| Jun 30, 2023 | -0.20 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -1.09 |
| Sep 30, 2022 | -1.18 |
| Jun 30, 2022 | -1.42 |
| Mar 31, 2022 | -1.20 |